Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human antithrombin III in congenital antithrombin III deficiency
CTR20180373Phase 3Completed
- Sponsor
- Shandong Taibang Biological Products
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antithrombin III in congenital antithrombin deficiency (ATD), sponsored by Shandong Taibang Biological Products. Started Apr 2018; status: completed.
02
Drugs
antithrombin III
03
Conditions
congenital antithrombin deficiency (ATD)
Beyond the preview
Go deeper on CTR20180373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180373.